Skip to main content

Sodium Chloride Irrigation: Package Insert / Prescribing Info

Package insert / product label
Dosage form: irrigation
Drug class: Miscellaneous topical agents

Medically reviewed by Drugs.com. Last updated on Sep 16, 2023.

Package Insert

PIC™ (Plastic Irrigation Container)

0.9% Sodium Chloride Irrigation USP

Isotonic Solution for Irrigation.

For Irrigation Only.

Not for Injection.

Rx only

Sodium Chloride Irrigation Description

Each 100 mL contains:
Sodium Chloride USP 0.9 g; Water for Injection USP qs

pH adjusted with Hydrochloric Acid NF
pH: 5.0 (4.5–7.0) Calculated Osmolarity: 310 mOsmol/liter

Concentration of Electrolytes (mEq/liter): Sodium 154; Chloride 154

0.9% Sodium Chloride Irrigation USP is sterile, nonpyrogenic, isotonic and contains no bacteriostatic or antimicrobial agents.

The formula of the active ingredient is:

IngredientMolecular FormulaMolecular Weight
Sodium Chloride USP NaCl 58.44

The plastic container is a copolymer of ethylene and propylene formulated and developed for parenteral drugs. The copolymer contains no plasticizers and exhibits virtually no leachability. The plastic container is also virtually impermeable to vapor transmission and, therefore, requires no overwrap to maintain the proper drug concentration. The safety of the plastic container has been confirmed by biological evaluation procedures. The material passes Class Vl testing as specified in the U.S. Pharmacopeia for Biological Tests — Plastic Containers. These tests have shown that the container is nontoxic and biologically inert.

Not made with natural rubber latex, PVC or DEHP.

Sodium Chloride Irrigation - Clinical Pharmacology

0.9% Sodium Chloride Irrigation USP is utilized for a variety of clinical indications such as sterile irrigation of body cavities, tissues or wounds, indwelling urethral catheters, surgical drainage tubes, and for washing, rinsing or soaking surgical dressings, instruments and laboratory specimens. It also serves as a diluent or vehicle for drugs used for irrigation or other pharmaceutical preparations.

0.9% Sodium Chloride Irrigation USP provides an isotonic saline irrigation identical in composition with 0.9% Sodium Chloride Injection USP (normal saline).

Physiological irrigation solutions are considered generally compatible with living tissues and organs.

Sodium, the major cation of the extracellular fluid, functions primarily in the control of water distribution, fluid balance, and osmotic pressure of body fluids. Sodium is also associated with chloride and bicarbonate in the regulation of the acid-base equilibrium of body fluid.

Chloride, the major extracellular anion, closely follows the metabolism of sodium, and changes in the acid-base balance of the body are reflected by changes in the chloride concentration.

Indications and Usage for Sodium Chloride Irrigation

0.9% Sodium Chloride Irrigation USP is indicated for all general irrigation, washing, rinsing and dilution purposes which permit use of a sterile, nonpyrogenic electrolyte solution.

Contraindications

0.9% Sodium Chloride Irrigation USP is not for injection by usual parenteral routes.

An electrolyte solution should not be used for irrigation during electrosurgical procedures.

Warnings

FOR IRRIGATION ONLY. NOT FOR INJECTION.

Irrigating fluids have been demonstrated to enter the systemic circulation in relatively large volumes; thus, irrigation solutions must be regarded as systemic drugs. Absorption of large amounts can cause fluid and/or solute overload resulting in dilution of serum electrolyte concentrations, overhydration, congested states or pulmonary edema.

The risk of dilutional states is inversely proportional to the electrolyte concentrations of the administered parenteral solutions. The risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentration.

Do not warm above 150°F (66°C).

After opening container, its contents should be used promptly to minimize the possibility of bacterial growth or pyrogen formation.

Discard unused portion of irrigating solution since it contains no preservatives.

Precautions

General

Use aseptic technique when preparing and administering sterile irrigation solutions.

Use only if solution is clear and container and seal are intact.

Do not use for irrigation that may result in absorption of large amounts of fluid into the blood.

Caution should be observed when the solution is used for continuous irrigation or allowed to “dwell” inside body cavities because of possible absorption into the blood stream and the production of circulatory overload.

When used for irrigation via appropriate irrigation equipment, the administration set should be attached promptly. Unused portions should be discarded and a fresh container of appropriate size used for the start up of each cycle or repeat procedure. For repeated irrigations of urethral catheters, a separate container should be used for each patient.

Laboratory Tests

Clinical evaluation and periodic laboratory determinations are necessary to monitor changes in fluid balance, electrolyte concentrations, and acid-base balance after prolonged irrigation, when fluid absorption is suspected, or whenever the condition of the patient warrants such evaluation.

Drug Interactions

Some additives may be incompatible. Consult with pharmacist. When introducing additives, use aseptic technique. Mix thoroughly. Do not store.

Carcinogenesis, Mutagenesis, Impairment of Fertility

Studies with 0.9% Sodium Chloride Irrigation USP have not been performed to evaluate carcinogenic potential, mutagenic potential, or effects on fertility.

Pregnancy

Teratogenic Effects

Animal reproduction studies have not been conducted with 0.9% Sodium Chloride Irrigation USP. It is also not known whether 0.9% Sodium Chloride Irrigation USP can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. 0.9% Sodium Chloride Irrigation USP should be given to a pregnant woman only if clearly needed.

Labor and Delivery

Safety and effectiveness of 0.9% Sodium Chloride Irrigation USP during labor and delivery have not been established. Caution should be exercised, and the fluid balance, glucose and electrolyte concentrations, and acid-base balance, of both mother and fetus should be evaluated periodically or whenever warranted by the condition of the patient or fetus.

Nursing Mothers

It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when 0.9% Sodium Chloride Irrigation USP is administered to a nursing woman.

Pediatric Use

The safety and effectiveness of 0.9% Sodium Chloride Irrigation USP in pediatric patients have not been established. Its limited use in pediatric patients has been inadequate to fully define proper dosage and limitations for use.

Geriatric Use

Clinical studies of 0.9% Sodium Chloride Irrigation USP did not include a sufficient number of patients age 65 years and over to determine whether they respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.

This drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with impaired renal function. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function. Frequent laboratory determinations and clinical evaluations are recommended to monitor changes in blood glucose, electrolyte concentrations, and renal function.

Adverse Reactions/Side Effects

Possible adverse effects arising from the irrigation of body cavities, tissues, or indwelling catheters and tubes can be minimized when proper procedures are followed. Displaced catheters or drainage tubes can lead to irrigation or infiltration of unintended structures or cavities. Excessive volume or pressure during irrigation of closed cavities may cause undue distension or disruption of tissues. Accidental contamination from careless technique may transmit infection.

If an adverse reaction does occur, discontinue administration of the irrigant, evaluate the patient, institute appropriate therapeutic countermeasures, and save the remainder of the fluid for examination if deemed necessary.

Overdosage

In the event of overhydration or solute overload, reevaluate the patient’s condition, and institute appropriate corrective treatment. Intravascular volume overload may respond to hemodialysis. See WARNINGS, PRECAUTIONS, and ADVERSE REACTIONS.

Sodium Chloride Irrigation Dosage and Administration

As required for irrigation.

When used as a diluent, or vehicle for other drugs, the drug manufacturer’s recommendations should be followed.

Some additives may be incompatible. Consult with pharmacist. When introducing additives, use aseptic techniques. Mix thoroughly. Do not store.

Solutions should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permits.

How is Sodium Chloride Irrigation supplied

0.9% Sodium Chloride Irrigation USP is supplied sterile and nonpyrogenic in PIC™ (Plastic Irrigation Container). The 1000 mL and 500 mL containers are packaged 16 per case.

NDC Cat. No. Size
0.9% Sodium Chloride Irrigation USP
0264-2201-00 R5200-01 1000 mL
0264-2201-10 R5201-01 500 mL

Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. Protect from freezing. Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F). [See USP Controlled Room Temperature.] However, brief exposure up to 40°C does not adversely affect the product.

Do not warm above 150°F (66°C).

Revised: June 2023

PIC is a trademark of B. Braun Medical Inc.

Directions for Use of PIC™ (Plastic Irrigation Container)

Not for injection.

Aseptic technique is required.

  1. Caution – Before use, perform the following checks:

    (a) Read the label. Ensure solution is the one ordered and is within the expiration date.

    (b) Invert container and inspect the solution in good light for cloudiness, haze, or particulate matter; check the
    container for leakage or damage. Any container which is suspect should not be used.

    Use only if solution is clear and container and seal are intact.

    Single-dose container. Discard unused portion.
  2. Outer Closure Removal – Grasp the container with one hand and turn the breakaway ring counterclockwise with the other hand until slight resistance is felt. Then, twisting the container in the opposite direction, turn the breakaway ring sharply until the entire outer cap is loose and can be lifted off. (Figure 1)
    Figure 1
  3. Connect the administration set through the sterile set port according to set instructions (Figure 2) or remove screw cap and pour.
    Figure 2
  4. Do not warm above 150°F (66°C) to assure minimal bottle distortion. Keep bottles upright.

B. Braun Medical Inc.
Bethlehem, PA 18018-3524 USA
1-800-227-2862

Y36-003-074 LD-769-1

PRINCIPAL DISPLAY PANEL - 1000 mL Container

0.9% Sodium Chloride Irrigation USP

Isotonic Solution for Irrigation

REF R5200-01
NDC 0264-2201-00

1000 mL
PIC™ Container

Rx only

Lot
Exp.

Each 100 mL contains:
Sodium Chloride USP 0.9 g
Water for Injection USP qs
pH adjusted with Hydrochloric
Acid NF

pH: 5.0 (4.5-7.0)
Calc. Osmolarity: 310 mOsmol/liter

Electrolytes (mEq/liter):
Sodium 154 Chloride 154

Sterile, nonpyrogenic. Single-dose container. Discard unused portion.

Not for Injection. Use only if solution is clear and container and seal are intact.

Warning: Do not warm above 150°F (66°C).

Store at 20°C to 25°C (68°F to 77°F). [See USP Controlled Room Temperature.] Avoid excessive heat. Protect from freezing.

Dosage: See Prescribing Information.

Not made with natural rubber latex, PVC or DEHP.

B. Braun Medical Inc.
Bethlehem, PA 18018-3524 USA
1-800-227-2862

Y37-002-590 LD-770-1

0.9% Sodium Chloride Irrigation USP

1000 mL Container Label R5200-01

PRINCIPAL DISPLAY PANEL - 500 mL Container

0.9% Sodium Chloride Irrigation USP

Isotonic Solution for Irrigation

REF R5201-01
NDC 0264-2201-10

500 mL
PIC™ Container

Rx only

Lot
Exp.

Each 100 mL contains:
Sodium Chloride USP 0.9 g
Water for Injection USP qs
pH adjusted with Hydrochloric
Acid NF

pH: 5.0 (4.5-7.0)
Calc. Osmolarity: 310 mOsmol/liter

Electrolytes (mEq/liter):
Sodium 154 Chloride 154

Sterile, nonpyrogenic. Single-dose container. Discard unused portion.

Not for Injection. Use only if solution is clear and container and seal are intact.

Warning: Do not warm above 150°F (66°C).

Store at 20°C to 25°C (68°F to 77°F). [See USP Controlled Room Temperature.] Avoid excessive heat. Protect from freezing.

Dosage: See Prescribing Information.

Not made with natural rubber latex, PVC or DEHP.

B. Braun Medical Inc.
Bethlehem, PA 18018-3524 USA
1-800-227-2862

Y37-002-591 LD-771-1

0.9% Sodium Chloride Irrigation USP

500 mL Container Label R5201-01
SODIUM CHLORIDE
sodium chloride irrigant
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:0264-2201
Route of AdministrationIRRIGATION
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X) (SODIUM CATION - UNII:LYR4M0NH37, CHLORIDE ION - UNII:Q32ZN48698) SODIUM CHLORIDE0.9 g in 100 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)
HYDROCHLORIC ACID (UNII: QTT17582CB)
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0264-2201-0016 in 1 CASE09/14/2009
11000 mL in 1 CONTAINER; Type 0: Not a Combination Product
2NDC:0264-2201-1016 in 1 CASE09/14/2009
2500 mL in 1 CONTAINER; Type 0: Not a Combination Product
3NDC:0264-2201-508 in 1 CASE09/14/200906/30/2022
32000 mL in 1 CONTAINER; Type 0: Not a Combination Product
4NDC:0264-2201-704 in 1 CASE09/14/200909/30/2021
44000 mL in 1 CONTAINER; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NDANDA01673309/14/2009
Labeler - B. Braun Medical Inc. (002397347)